Home > Publications database > Correction: Jarahian et al. Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape. Cancers 2021, 13, 5203. > print

001     303227
005     20250731114306.0
024 7 _ |a 10.3390/cancers17142362
|2 doi
024 7 _ |a pmid:40723294
|2 pmid
037 _ _ |a DKFZ-2025-01578
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Jarahian, Mostafa
|0 P:(DE-He78)3ac0bc7cf0e8ab1e1bc05c7889bfa3df
|b 0
|e First author
245 _ _ |a Correction: Jarahian et al. Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape. Cancers 2021, 13, 5203.
260 _ _ |a Basel
|c 2025
|b MDPI
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753941519_19397
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:G401#LA:G401#
520 _ _ |a There was an error in the original publication [...].
536 _ _ |a 319H - Addenda (POF4-319H)
|0 G:(DE-HGF)POF4-319H
|c POF4-319H
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Marofi, Faroogh
|b 1
700 1 _ |a Maashi, Marwah Suliman
|b 2
700 1 _ |a Ghaebi, Mahnaz
|b 3
700 1 _ |a Khezri, Abdolrahman
|0 0000-0003-1061-8229
|b 4
700 1 _ |a Berger, Martin
|0 P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676
|b 5
|e Last author
773 _ _ |a 10.3390/cancers17142362
|g Vol. 17, no. 14, p. 2362 -
|0 PERI:(DE-600)2527080-1
|n 14
|p 2362
|t Cancers
|v 17
|y 2025
|x 2072-6694
909 C O |o oai:inrepo02.dkfz.de:303227
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)3ac0bc7cf0e8ab1e1bc05c7889bfa3df
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-319H
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Addenda
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCERS : 2022
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-14
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-14
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-14
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-14
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCERS : 2022
|d 2024-12-14
920 2 _ |0 I:(DE-He78)G401-20160331
|k G401
|l Molekulare Toxikologie und Chemotherapie
|x 0
920 0 _ |0 I:(DE-He78)G401-20160331
|k G401
|l Molekulare Toxikologie und Chemotherapie
|x 0
920 1 _ |0 I:(DE-He78)G401-20160331
|k G401
|l Molekulare Toxikologie und Chemotherapie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G401-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21